Weiterführende Literatur
Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA et al (2013) Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 32:141–156
Schaffer JM, Arnaoutakis GJ, Allen JG, Weiss ES, Patel ND, Russell SD et al (2011) Bleeding complications and blood product utilization with left ventricular assist device implantation. Ann Thorac Surg 91:740–749
Yang JA, Kato TS, Shulman BP, Takayama H, Farr M, Jorde UP et al (2012) Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and Meld eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant 31:601–610
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871
Chokshi A, Cheema FH, Schaefle KJ, Jiang J, Collado E, Shahzad K et al (2012) Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transplant 31:591–600
Schmitto JD, Molitoris U, Haverich A, Strueber M (2012) Implantation of a centrifugal pump as a left ventricular assist device through a novel, minimized approach: upper hemisternotomy combined with anterolateral thoracotomy. J Thorac Cardiovasc Surg 143(2):511–513
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Interessenkonflikt
J.S. Hanke und J.D. Schmitto geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Hanke, J.S., Schmitto, J.D. Leberfunktion bei LVAD-Implantation. Z Herz- Thorax- Gefäßchir 29, 262–263 (2015). https://doi.org/10.1007/s00398-015-0001-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00398-015-0001-1